ResearchAndMarkets adds 300-page life sciences asset deals report

Verifying
  • ResearchAndMarkets.com added CurrentPartnering's report on pharmaceutical and biotechnology asset purchase deals.
  • The 300-page report covers 1,107 companies and transactions announced since 2019.
  • CurrentPartnering's database draws on press releases, company filings, investor presentations and SEC filings.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.